{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:01:39Z","timestamp":1787749299177,"version":"build-2784847793"},"reference-count":43,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070963"],"award-info":[{"award-number":["81070963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400068"],"award-info":[{"award-number":["81400068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2010HM019"],"award-info":[{"award-number":["ZR2010HM019"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2017.00230","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T10:31:21Z","timestamp":1496226681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis"],"prefix":"10.3389","volume":"8","author":[{"given":"Yanchen","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda L.","family":"Kusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Kaminski","given":"Henry J.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.410150316","article-title":"Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients","volume":"15","author":"Pascuzzi","year":"1984","journal-title":"Ann Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1212\/WNL.34.2.170","article-title":"Myasthenia gravis: prolonged treatment with steroids","volume":"34","author":"Sghirlanzoni","year":"1984","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1600-0404.1991.tb04899.x","article-title":"Effectiveness of steroid treatment in myasthenia gravis: a retrospective study","volume":"84","author":"Cosi","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"B7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000116785","article-title":"Long-term results of corticosteroid therapy in patients with myasthenia gravis","volume":"32","author":"Evoli","year":"1992","journal-title":"Eur Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/ene.13040","article-title":"GR gene polymorphism is associated with inter-subject variability in response to glucocorticoids in patients with myasthenia gravis","volume":"23","author":"Xie","year":"2016","journal-title":"Eur J Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1212\/WNL.0b013e318239b9ae","article-title":"SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment","volume":"77","author":"Kyriakides","year":"2011","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e29309","DOI":"10.1371\/journal.pone.0029309","article-title":"The role of osteopontin (OPN\/SPP1) haplotypes in the susceptibility to Crohn\u2019s disease","volume":"6","author":"Glas","year":"2011","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1292\/jvms.68.379","article-title":"Increased expression of osteopontin in the heart tissue of Lewis rats with experimental autoimmune myocarditis","volume":"68","author":"Shin","year":"2006","journal-title":"J Vet Med Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1167\/iovs.06-0064","article-title":"Osteopontin is proinflammatory in experimental autoimmune uveitis","volume":"47","author":"Hikita","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B14","first-page":"772","article-title":"Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis","volume":"30","author":"Binder","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1172\/JCI46387","article-title":"Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis","volume":"121","author":"Song","year":"2011","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","article-title":"Osteopontin: role in immune regulation and stress responses","volume":"19","author":"Wang","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/jnnp-2014-308409","article-title":"Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants","volume":"86","author":"van den Bergen","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mus.23839","article-title":"A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis","volume":"48","author":"Howard","year":"2013","journal-title":"Muscle Nerve"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/mus.21142","article-title":"Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis","volume":"38","author":"Wolfe","year":"2008","journal-title":"Muscle Nerve"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","article-title":"Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity","volume":"64","author":"Bedlack","year":"2005","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1196\/annals.1405.040","article-title":"Myasthenia gravis in the elderly: is it different?","volume":"1132","author":"Aarli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cccn.2005.05.035","article-title":"A sensitive non-isotopic assay for acetylcholine receptor autoantibodies","volume":"364","author":"Hewer","year":"2006","journal-title":"Clin Chim Acta"},{"key":"B25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1469-1809.2008.00469.x","article-title":"Efficient association study design via power-optimized tag SNP selection","volume":"72","author":"Han","year":"2008","journal-title":"Ann Hum Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3892\/or.2013.2632","article-title":"An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer","volume":"30","author":"Ramchandani","year":"2013","journal-title":"Oncol Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.humimm.2013.09.014","article-title":"Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk","volume":"75","author":"Wang","year":"2014","journal-title":"Hum Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1136\/annrheumdis-2013-204581","article-title":"Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene","volume":"74","author":"Gazal","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12032-014-0020-x","article-title":"Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma","volume":"31","author":"Wang","year":"2014","journal-title":"Med Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0001757","DOI":"10.1371\/journal.pone.0001757","article-title":"Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction","volume":"3","author":"Han","year":"2008","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/ped.2011.0095","article-title":"Polymorphism in osteopontin gene (SPP1) is associated with asthma and related phenotypes in a Puerto Rican population","volume":"24","author":"Arjomandi","year":"2011","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1136\/annrheumdis-2014-205539","article-title":"SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis","volume":"73","author":"Juge","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1038\/srep14164","article-title":"OPN gene polymorphisms, rs17524488 GG\/G, rs11730582 T\/C, and rs9138 C\/A, and cancer risk in a Chinese population","volume":"5","author":"Mi","year":"2015","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cell.2013.09.043","article-title":"Dynamic trans-acting factor colocalization in human cells","volume":"155","author":"Xie","year":"2013","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ng.2205","article-title":"Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles","volume":"44","author":"Fairfax","year":"2012","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1101\/gr.100552.109","article-title":"Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificities","volume":"20","author":"Jolma","year":"2010","journal-title":"Genome Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1000214","DOI":"10.1371\/journal.pgen.1000214","article-title":"High-resolution mapping of expression-QTLs yields insight into human gene regulation","volume":"4","author":"Veyrieras","year":"2008","journal-title":"PLoS Genet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1177\/0022034515605270","article-title":"Osteopontin in immune-mediated diseases","volume":"94","author":"Rittling","year":"2015","journal-title":"J Dent Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3109\/08916934.2013.830714","article-title":"Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: a prospective cohort study","volume":"46","author":"Zou","year":"2013","journal-title":"Autoimmunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/mus.24214","article-title":"The modified Rankin scale to assess disability in myasthenia gravis: comparing with other tools","volume":"50","author":"Farrugia","year":"2014","journal-title":"Muscle Nerve"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1167\/iovs.14-14422","article-title":"RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment","volume":"55","author":"Zhou","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.4049\/jimmunol.1600987","article-title":"Osteopontin in spontaneous germinal centers inhibits apoptotic cell engulfment and promotes anti-nuclear antibody production in Lupus-prone mice","volume":"197","author":"Sakamoto","year":"2016","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mus.23330","article-title":"Recommendations for myasthenia gravis clinical trials","volume":"45","author":"Benatar","year":"2012","journal-title":"Muscle Nerve"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00230\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T10:31:26Z","timestamp":1496226686000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00230\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":43,"alternative-id":["10.3389\/fneur.2017.00230"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2017.00230","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,31]]},"article-number":"230"}}